SCM
TLSI icon

Sterling Capital Management’s TriSalus Life Sciences TLSI Stock Holding History

Sterling Capital Management’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.96K Sell
740
-631
-46% -$3.09K ﹤0.01% 2897
2025
Q4 		$9.57K Buy
1,371
+373
+37% +$2.09K ﹤0.01% 2623
2025
Q3 		$4.64K Buy
998
+659
+194% +$3.09K ﹤0.01% 2784
2025
Q2 		$1.85K Buy
+339
New +$1.82K ﹤0.01% 2936

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Sterling Capital Management's TLSI Position: Q1 2026 in Review

Sterling Capital Management reduced its TriSalus Life Sciences (TLSI) stake by 46% in Q1 2026, selling an estimated $3.09K and leaving 740 shares worth $2.96K. The position accounts for ﹤0.01% of the portfolio, ranked #2897.

Sterling Capital Management first reported a position in TLSI in Q2 2025 and has held it in 4 quarters since. The position peaked at $9.57K in Q4 2025. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • Sterling Capital Management held 740 shares of TriSalus Life Sciences worth $2.96K as of Q1 2026.
  • Sterling Capital Management sold 631 TriSalus Life Sciences shares in Q1 2026, an estimated $3.09K.
  • TriSalus Life Sciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #2897 holding.
  • Sterling Capital Management first reported a position in TriSalus Life Sciences in Q2 2025 and has held it in 4 quarters since.
  • Sterling Capital Management's TriSalus Life Sciences position peaked at $9.57K in Q4 2025.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.